This article originally appeared on the REQ blog.
Hope. It is a phrase often used in conjunction with a cure for a disease and conditions, a promising positive outlook that one day, a cure will be found for a disease or condition.
However, for many investigational products that moment of hope may never come. Efforts to get participants enrolled in clinical trials—a necessary part of each product approval that tests the product for safety and efficacy—often fall shorts, delaying or halting entirely the drug development process. Read more “Still Waiting on a Medical Breakthrough? Clinical Trial Recruitment Efforts Could Be to Blame”